Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    64,016.07
    -616.81 (-0.95%)
     

  • CMC Crypto 200

    1,334.16
    -62.37 (-4.47%)
     

  • S&P 500

    5,109.45
    +61.03 (+1.21%)
     

  • Dow

    38,306.43
    +220.63 (+0.58%)
     

  • Nasdaq

    15,943.73
    +331.97 (+2.13%)
     

  • Gold

    2,351.90
    +9.40 (+0.40%)
     

  • Crude Oil

    83.76
    +0.19 (+0.23%)
     

  • 10-Yr Bond

    4.6710
    -0.0350 (-0.74%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Why Vir Biotechnology Is Up More Than 13% Today

James Brumley, The Motley Fool
·1-min read
Why Vir Biotechnology Is Up More Than 13% Today

Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.

Continue reading